Next, we tested the in vitro antitumor activity of CSPG4 CAR T cells by co-culturing them with thyroid cancer cells at multiple effector (CAR T) to target (cancer cells) (E: T) ratios, ranging from 1:1 to 1:32. This evidence concerns the gene CSPG4 and thyroid cancer.